These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37869289)
1. Effects of somatostatin analogs on uptake of radiolabeled somatostatin analogs on imaging: a systematic review and meta-analysis. Wang R; Guo L; Pan L; Tian R; Shen G Quant Imaging Med Surg; 2023 Oct; 13(10):6814-6826. PubMed ID: 37869289 [TBL] [Abstract][Full Text] [Related]
2. A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on Gålne A; Almquist H; Almquist M; Hindorf C; Ohlsson T; Nordenström E; Sundlöv A; Trägårdh E J Nucl Med; 2019 Dec; 60(12):1717-1723. PubMed ID: 31000584 [TBL] [Abstract][Full Text] [Related]
6. Detection of Bone Metastases by Tian R; Xie Q; Yu F; Du C; Yao X; Zang S; Zhang C; Zhang P; Shao G; Yang Z; Wang F; Yu J Contrast Media Mol Imaging; 2022; 2022():1750132. PubMed ID: 36447752 [TBL] [Abstract][Full Text] [Related]
7. Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of Lodge MA; Solnes LB; Chaudhry MA; Wahl RL Mol Imaging Biol; 2021 Oct; 23(5):766-774. PubMed ID: 33829361 [TBL] [Abstract][Full Text] [Related]
8. Real-world comparison of healthcare resource utilization and costs of [ Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of SSTR2 Expression Assessed by Fonti R; Panico M; Pellegrino S; Pulcrano A; Vastarella LA; Torbati AHM; Giuliano M; Palmieri G; De Placido S; Del Vecchio S J Nucl Med; 2022 Oct; 63(10):1509-1514. PubMed ID: 35273092 [TBL] [Abstract][Full Text] [Related]
10. Biodistribution and first clinical results of Ilhan H; Lindner S; Todica A; Cyran CC; Tiling R; Auernhammer CJ; Spitzweg C; Boeck S; Unterrainer M; Gildehaus FJ; Böning G; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Bartenstein P Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):870-880. PubMed ID: 31492994 [TBL] [Abstract][Full Text] [Related]
11. The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors. Chahid Y; Hashimi K; van de Garde EMW; Klümpen HJ; Hendrikse NH; Booij J; Verberne HJ Clin Nucl Med; 2023 Sep; 48(9):757-762. PubMed ID: 37486312 [TBL] [Abstract][Full Text] [Related]
12. Changes in biodistribution on Cherk MH; Kong G; Hicks RJ; Hofman MS Cancer Imaging; 2018 Jan; 18(1):3. PubMed ID: 29361984 [TBL] [Abstract][Full Text] [Related]
13. Influence of lanreotide on uptake of Aalbersberg EA; de Wit-van der Veen BJ; Versleijen MWJ; Saveur LJ; Valk GD; Tesselaar MET; Stokkel MPM Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):696-703. PubMed ID: 30097670 [TBL] [Abstract][Full Text] [Related]
14. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [ Eschbach RS; Hofmann M; Späth L; Sheikh GT; Delker A; Lindner S; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Tiling R; Brendel M; Wenter V; Dekorsy FJ; Zacherl MJ; Todica A; Ilhan H; Grawe F; Cyran CC; Unterrainer M; Rübenthaler J; Knösel T; Paul T; Boeck S; Westphalen CB; Spitzweg C; Auernhammer CJ; Bartenstein P; Unterrainer LM; Beyer L Front Oncol; 2023; 13():992316. PubMed ID: 36793617 [TBL] [Abstract][Full Text] [Related]
15. Potential for Increasing Uptake of Radiolabeled Pollard JH; Menda Y; Zamba KD; Madsen M; O'Dorisio MS; O'Dorisio T; Bushnell D Cancer Biother Radiopharm; 2021 Oct; 36(8):632-641. PubMed ID: 34252288 [No Abstract] [Full Text] [Related]
16. Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects. Mazziotti G; Mosca A; Frara S; Vitale G; Giustina A Expert Opin Pharmacother; 2017 Nov; 18(16):1679-1689. PubMed ID: 29067877 [TBL] [Abstract][Full Text] [Related]
17. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. Kwekkeboom DJ; Mueller-Brand J; Paganelli G; Anthony LB; Pauwels S; Kvols LK; O'dorisio TM; Valkema R; Bodei L; Chinol M; Maecke HR; Krenning EP J Nucl Med; 2005 Jan; 46 Suppl 1():62S-6S. PubMed ID: 15653653 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? Merola E; Alonso Gordoa T; Zhang P; Al-Toubah T; Pellè E; Kolasińska-Ćwikła A; Zandee W; Laskaratos F; de Mestier L; Lamarca A; Hernando J; Cwikla J; Strosberg J; de Herder W; Caplin M; Cives M; van Leeuwaarde R Oncologist; 2021 Apr; 26(4):294-301. PubMed ID: 33301235 [TBL] [Abstract][Full Text] [Related]
19. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531 [TBL] [Abstract][Full Text] [Related]